Lateral Flow Assay Components Market Size and Growth Forecast North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands), Asia Pacific (Japan, China, India, Australia), Latin America (Brazil, Mexico, Argentina)
The global lateral flow assay (LFA) components market is projected to grow from USD 0.39 billion in 2025 to USD 0.49 billion by 2030, at a compound annual growth rate (CAGR) of 4.4%. This growth is primarily driven by rising health awareness and a significant shift toward home-based healthcare and point-of-care (POC) testing solutions.
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=45058941
What...
Microsampling Devices Market Size and Growth Forecast North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands), Asia Pacific (Japan, China, India, Australia), Latin America (Brazil, Mexico, Argentina)
The global at-home blood collection devices market was valued at USD 89.4 million in 2023 and stood at USD 93.5 million in 2024. It is projected to reach USD 135.0 million by 2029, advancing at a compound annual growth rate (CAGR) of 7.6% during the forecast period from 2024 to 2029. This growth is primarily driven by the rising prevalence of chronic disorders, increasing consumer awareness regarding...
Microbiome Diagnostics Market Size and Growth Forecast North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands), Asia Pacific (Japan, China, India, Australia), Latin America (Brazil, Mexico, Argentina)
The global microbiome diagnostics market, valued at US$146 million in 2023, is projected to advance at a resilient CAGR of 15.5% from 2023 to 2028, culminating in a forecasted valuation of US$300 million by the end of the period. This growth is primarily fueled by the rising incidence of chronic diseases, increasing collaborative efforts between the microbiome industry and academic institutes, and...
IVD Contract Manufacturing Market Size and Growth Forecast North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands), Asia Pacific (Japan, China, India, Australia), Latin America (Brazil, Mexico, Argentina)
The global IVD contract manufacturing market was valued at US$15.4 billion in 2023 and is projected to reach US$26.7 billion by 2028. This growth represents a resilient compound annual growth rate (CAGR) of 11.5% during the forecast period from 2023 to 2028. The expansion is primarily driven by the increasing need for cost-effective diagnostic equipment, the rising prevalence of chronic and infectious...
Stem Cell Assays Market Size and Growth Forecast North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands), Asia Pacific (Japan, China, India, Australia), Latin America (Brazil, Mexico, Argentina)
The global stem cell assays market was valued at USD 1.9 billion in 2022 and is projected to reach USD 4.5 billion by 2027. This expansion represents a compound annual growth rate (CAGR) of 17.7% during the forecast period from 2022 to 2027. The market’s growth is primarily fueled by increasing awareness of the therapeutic potency of stem cells, rising demand for cell-based assays in drug discovery,...
Interactive Patient Care Market Size and Growth Forecast North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands), Asia Pacific (Japan, China, India, Australia), Latin America (Brazil, Mexico, Argentina)
The global interactive patient care market is projected to reach USD 300 million by 2027 from USD 146 million in 2022, at a CAGR of 15.5%. This growth is driven by the increasing demand for improved interactive patient engagement solutions, a rising number of collaborations and partnerships between stakeholders, and favorable government initiatives to promote the adoption of these solutions.
Download...
Ablation Technology Market Size and Growth Forecast North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands), Asia Pacific (Japan, China, India, Australia), Latin America (Brazil, Mexico, Argentina)
The global ablation technology market was valued at US$6.11 billion in 2024 and is projected to reach US$9.62 billion by 2029. This growth represents a resilient compound annual growth rate (CAGR) of 9.5% during the forecast period from 2024 to 2029. The market expansion is primarily driven by expanding access to healthcare services, an increasing preference for minimally invasive treatments, and...
AI in Remote Patient Monitoring (RPM) Market Size and Growth Forecast North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Netherlands), Asia Pacific (Japan, China, India, Australia), Latin America (Brazil, Mexico, Argentina)
The global AI in remote patient monitoring market is projected to reach USD 8.44 billion by 2030 from USD 1.97 billion in 2024, at a high compound annual growth rate (CAGR) of 27.5% during the forecast period. This significant expansion is driven by the increasing prevalence of chronic diseases, a global shift toward digital health adoption, and a rising demand for predictive, home-based patient care...
HLA Typing for Transplant: Advancing Precision in Organ Matching and Patient Outcomes
The global healthcare ecosystem is witnessing a steady rise in organ transplantation procedures, positioning human leukocyte antigen (HLA) typing as a critical component in ensuring transplant success. The HLA typing for transplant market is projected to grow from USD 1.1 billion in 2025 to USD 1.4 billion by 2030, registering a CAGR of 6.0%. This growth reflects not only technological advancements...
Drug Screening Market worth $21.29 billion by 2030
The global drug screening market, valued at US$8.92 billion in 2024, stood at US$10.36 billion in 2025 and is projected to advance at a resilient CAGR of 15.5% from 2025 to 2030, culminating in a forecasted valuation of US$21.29 billion by the end of the period.
Drug Screening Market Trends & Insights:
The oral fluid samples segment is projected to register the highest CAGR of 17.1% during...